Market Cap (In INR)
191.77 Billion
Revenue (In INR)
20.09 Billion
Net Income (In INR)
3.91 Billion
Avg. Volume
21.41 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 810.1-1593.0
- PE
- -
- EPS
- -
- Beta Value
- 0.326
- ISIN
- INE406M01024
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Amit Indubhushan Bakshi
- Employee Count
- -
- Website
- https://www.eris.co.in
- Ipo Date
- 2017-06-29
- Details
- Eris Lifesciences Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, anti-infective, blood related, cardiovascular, dermatology, gastrointestinal, gastroenterology, haematinics, hormones, nero/ central nervous system, neuropsychiatry, otologicals, pain/analgesics, respiratory, stomatologicals, cosmetology, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. The company offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
More Stocks
-
PAEKYPT Aneka Tambang Tbk
PAEKY
-
VPT
-
FLUIDOMFluidomat Limited
FLUIDOM
-
WAA
-
WTW
-
BCDMFKuuhubb Inc.
BCDMF
-
TELECANORTelecanor Global Limited
TELECANOR
-
0REZAddLife AB (publ)
0REZ